Tuesday, May 20, 2008

So, farewell then, Jean-Paul Garnier

Jean-Pierre Garnier, the GlaxoSmithKline chief executive, probably expected an easy ride when he appeared on Radio 4's Today to puff the firm's anti-bird flu vaccine.

He didn't get it.

James Naughtie laid into an increasingly furious Garnier about the criticism that GSK came in for over Seroxat, the antidepressant drug linked to suicides among children. “Does this mean that all the information GSK holds on the development of Seroxat (aka Paxil) will be put in the public domain?” Naughtie asked. This comprised “millions of documents, millions”, Garnier countered, saying that all had been made available to watchdogs.

Naughtie pressed him further.
“I'm not interested in answering this question. We've dealt with this subject. Thank you for taking the time to hear about the [bird flu] pandemic.” And Garnier was off. It might not have helped that Naughtie referred to a man who clearly takes himself very seriously as “Jean-Paul Garnier”.
Garnier hands over the helm to Andrew Witty at Thursday's AGM.

1 comment:

Truthman30 said...

Au revoir Indeed.